Areas of Expertise

Dr Chris Rutkowski performs a range of tests and treatments including:

• Drug and food provocation tests (challenges)
• Skin and blood tests for all types of allergy (food, drugs, pollen, pets etc)
• ISAC test and molecular tests (component resolved diagnosis)
• Anti-IgE (omalizumab) for urticaria and angioedema
• Desensitisation (immunotherapy) for pollen, house dust mite and animal allergy
• Management of severe hay fever and allergic sinusitis

Some of the conditions he commonly treats are:

• Anaphylaxis
• Drug and vaccine allergy
• Food allergy
• Rhinoconjunctivitis / hay fever
• Urticaria and angioedema

About Dr Chris Rutkowski

Dr Chris Rutkowski has extensive experience in all aspects of allergy care. He sees patients with anaphylaxis, food allergy, urticaria and angioedema, drug, vaccine and latex allergy, gastrointestinal allergy, venom allergy, allergic asthma, hay fever, allergic and nonallergic rhinitis/sinusitis/conjunctivitis and offers desensitisation (immunotherapy) treatment.

Dr Rutkowski is a published author in the field of drug allergy and contributes increasingly to the education and training of MSc students, allergists, dermatologists, GPs and general physicians at a national and international level.

He is President of the Clinical Immunology and Allergy Section of the Royal Society of Medicine and a member of: British Society for Allergy and Clinical Immunology, European Academy of Allergy and Clinical Immunology, American Academy of Allergy, Asthma and Immunology.

Research Highlights

Dr Chris Rutkowski has achieved multiple publications in peer-reviewed journals.

Key Publications

• Adverse reactions to COVID-19 vaccines: a practical approach. Rutkowski K, Mirakian R, Till S, Rutkowski R, Wagner A. Clin Exp Allergy. 2021 Apr 4. doi: 10.1111/cea.13880
• Piperacillin-tazobactam hypersensitivity: A large, multicenter analysis. Casimir-Brown RS, Kennard L, Kayode OS, Siew LQC, Makris M, Tsilochristou O, Chytiroglou E, Nakonechna A, Rutkowski K, Mirakian R, Wagner A. J Allergy Clin Immunol Pract. 2021 May;9:2001-2009.
• The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Kocaturk E, ….  Rutkowski K et al. Allergy. 2021 Mar;76:816-830.
• “Omalizumab plus”: combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: a multicenter UK series. Rutkowski K, Wagner A, Jui-Lin Choo K, Smith H, Savic S, Grattan CE. J Allergy Clin Immunol Pract. 2021 Mar;9:1400-1401.e2.
• Synchronous telemedicine in allergy: lessons learned and transformation of care during the COVID-19 pandemic. Thomas I, Siew LQC, Rutkowski K.J Allergy C lin Immunol Pract. 2021 Jan;9:170-176.e1.
• Immediate hypersensitivity reactions to steroids and steroid-containing medications. Rutkowski K, Wagner A, Rutkowski R. Curr Opin Allergy Clin Immunol. 2020;20:362-366[ ]
• Alpha-gal syndrome: An emerging cause of food and drug allergy. Rutkowski K, Wagner A, Rutkowski R, Sowa P, Pancewicz S, Moniuszko-Malinowska A.  Clin Exp Allergy. 2020;50:894-903
• Polyethylene glycol may be the major allergen in depot medroxy-progesterone acetate. Lu IN, Rutkowski K, Kennard L, Nakonechna A, Mirakian R, Wagner A.  J Allergy Clin Immunol Pract. 2020:3194-3197
• Flucloxacillin hypersensitivity: patient outcomes in a multicenter retrospective study. Kennard L, Rutkowski K, Siew LQC, Nakonechna A, Sargur R, Egner W, Shrimpton A, Mirakian R, Wagner A. J Allergy Clin Immunol Pract. 2019;7:2212-2217.e1.
• A multicenter evaluation of diagnosis and management of omega-5 gliadin allergy (also known as wheat-dependent exercise-induced anaphylaxis) in 132 adults. Kennnard L, Thomas I, Rutkowski K, Azzu V, Yong PFK, Kasternow B, Hunter H, Cabdi NMO, Nakonechna A, Wagner A. J Allergy Clin Immunol Pract. 2018;6:1892-1897.

Steroid allergy: clinical features and the importance of excipient testing in a diagnostic algorithm. Li PH, Wagner A, Thomas I, Watts TJ, Rutkowski R, Rutkowski K. J Allergy Clin Immunol Pract. 2018;6:1655-1661.